These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

788 related items for PubMed ID: 16784958

  • 1. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T, Hirano T, Yamamoto T, Ito Y, Adachi M.
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [Abstract] [Full Text] [Related]

  • 2. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
    Kostapanos MS, Milionis HJ, Filippatos TD, Nakou ES, Bairaktari ET, Tselepis AD, Elisaf MS.
    Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
    [Abstract] [Full Text] [Related]

  • 3. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
    Waysbort J, Regitz G, Brunner D.
    Clin Ther; 1988 Jul; 10(4):392-400. PubMed ID: 3152618
    [Abstract] [Full Text] [Related]

  • 4. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM, van Greevenbroek MM, Krauss RM, Brouwers MC, Vermeulen VM, Robertus-Teunissen MG, van der Kallen CJ, de Bruin TW.
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [Abstract] [Full Text] [Related]

  • 5. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB, Fitzsimons O, Moreno S, Owens D, Collins P, Johnson A, Tomkin GH.
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [Abstract] [Full Text] [Related]

  • 6. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J, James RW, Makoundou V, Bioletto S, Golay A.
    Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
    [Abstract] [Full Text] [Related]

  • 7. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS, Aslam M, Naveed AK, Razi MS.
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl.
    Cromwell WC, Otvos JD.
    Am J Cardiol; 2006 Dec 15; 98(12):1599-602. PubMed ID: 17145217
    [Abstract] [Full Text] [Related]

  • 9. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
    Packard CJ, Munro A, Lorimer AR, Gotto AM, Shepherd J.
    J Clin Invest; 1984 Dec 15; 74(6):2178-92. PubMed ID: 6511922
    [Abstract] [Full Text] [Related]

  • 10. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G, De Natale C, Iovine C, Patti L, Di Marino L, Coppola S, Del Prato S, Riccardi G, Rivellese AA.
    Arterioscler Thromb Vasc Biol; 2004 Dec 15; 24(12):2397-402. PubMed ID: 15458975
    [Abstract] [Full Text] [Related]

  • 11. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C, Gibney J, Owens D, Collins P, Johnson A, Tomkin GH.
    Diabet Med; 1997 Dec 15; 14(12):1051-8. PubMed ID: 9455933
    [Abstract] [Full Text] [Related]

  • 12. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan 15; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 13. The effects of glibenclamide and insulin on plasma high density lipoprotein in diabetics.
    Tamai T, Nakai T, Yamada S, Kobayashi T, Hayashi T, Kutsumi Y, Oida K, Takeda R.
    Artery; 1981 Jan 15; 9(6):477-93. PubMed ID: 6802107
    [Abstract] [Full Text] [Related]

  • 14. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
    Waysbort J, Regitz G, Chaimowitz D, Tuval M, Nakash I, Brunner D.
    Clin Ther; 1988 Jan 15; 10(4):358-71. PubMed ID: 2978874
    [Abstract] [Full Text] [Related]

  • 15. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
    Meas T, Laloi-Michelin M, Virally M, Peynet J, Giraudeaux V, Kévorkian JP, Guillausseau PJ.
    Eur J Intern Med; 2009 Mar 15; 20(2):197-200. PubMed ID: 19327612
    [Abstract] [Full Text] [Related]

  • 16. [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].
    Hayashi T, Hirano T, Shiobara T, Suguro T, Adachi M.
    Rinsho Byori; 2006 Jun 15; 54(6):569-75. PubMed ID: 16872005
    [Abstract] [Full Text] [Related]

  • 17. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov 15; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 18. Diabetic dyslipidaemia.
    Erkelens DW.
    Eur Heart J; 1998 Jul 15; 19 Suppl H():H27-40. PubMed ID: 9717062
    [Abstract] [Full Text] [Related]

  • 19. Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease.
    Barbagallo CM, Rizzo M, Noto D, Frasheri A, Pernice V, Rubino A, Pieri D, Pinto V, Cefalù AB, Giordano C, Notarbartolo A, Averna MR.
    Metabolism; 2006 May 15; 55(5):662-8. PubMed ID: 16631444
    [Abstract] [Full Text] [Related]

  • 20. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 15; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.